» Articles » PMID: 12140514

Computed Tomography Appearances of Hypervascular Hepatic Tumors After Percutaneous Radiofrequency Ablation Therapy

Overview
Specialty Radiology
Date 2002 Jul 26
PMID 12140514
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

A retrospective review of the computed tomography (CT) findings of patients with hypervascular liver tumors (26 hepatocellular carcinomas and 2 metastases [1 periampullary carcinoma and 1 neuroendocrine tumor]) who underwent percutaneous ultrasound-guided radiofrequency ablation (RFA) was performed. CT images consisted of nonenhanced and dual-phase contrast-enhanced helical CT images performed on a multidetector CT scan. Findings indicative of adequate tumor ablation on multidetector CT scanwere complete nonenhancement of the treated tumor with or without faint, thin, peripheral rim enhancement. Ablated lesions that showed complete nonenhancement on initial and subsequent follow-up CT examinations either remained stable or became progressively smaller. Thick rim or nodular peripheral enhancement was indicative of tumor residual or recurrence.

Citing Articles

Analysis of iodinated contrast delivered during thermal ablation: is material trapped in the ablation zone?.

Wu P, Brace C Phys Med Biol. 2016; 61(16):6041-54.

PMID: 27452478 PMC: 5361223. DOI: 10.1088/0031-9155/61/16/6041.


Imaging Features of Radiofrequency Ablation with Heat-Deployed Liposomal Doxorubicin in Hepatic Tumors.

Hong C, Chow L, Turkbey E, Lencioni R, Libutti S, Wood B Cardiovasc Intervent Radiol. 2015; 39(3):409-16.

PMID: 26228246 PMC: 4733610. DOI: 10.1007/s00270-015-1186-0.


Dual-energy CT after radiofrequency ablation of liver, kidney, and lung lesions: a review of features.

Vandenbroucke F, van Hedent S, Van Gompel G, Buls N, Craggs G, Vandemeulebroucke J Insights Imaging. 2015; 6(3):363-79.

PMID: 25941033 PMC: 4444790. DOI: 10.1007/s13244-015-0408-y.